| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C321-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-00 |
| filingDate |
2005-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165996accb423b3b152d8db0779397c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e49c8a1473bbc3dacafad6a23feb9778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ff9e4976a4ddd4f90b3b2ac33fcfe0 |
| publicationDate |
2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7179926-B2 |
| titleOfInvention |
Aryloxyalkylamine NK-1/SSRI inhibitors |
| abstract |
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts and solvates, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both. |
| priorityDate |
2004-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |